{"transactions":[{"id":938316,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2026-01-15T21:00:06.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":28.73,"value":2873000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction reported was $28.73, and the range of prices were between $28.50 and $29.18. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":139727,"source":{"system":"sec-edgar","filing":"0001579397-26-000002","document":"form4-01152026_090101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000157939726000002/form4-01152026_090101.xml","form_type":"4"}},{"id":938315,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2026-01-15T21:00:06.000Z","date":"2026-01-13","kind":"sale","planned":false,"acquired":false,"shares":3822,"price":28.01,"value":107054.22,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction reported was $28.01, and the range of prices were between $28.00 and $28.03. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":239727,"source":{"system":"sec-edgar","filing":"0001579397-26-000002","document":"form4-01152026_090101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000157939726000002/form4-01152026_090101.xml","form_type":"4"}},{"id":975579,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2025-12-09T21:00:09.000Z","date":"2025-12-08","kind":"gift","planned":false,"acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person transferred 75,000 shares to the Kovacs 2025 Family Trust as a bona fide gift for no consideration. The reporting person does not have voting, dispositive, or pecuniary interest over any of the securities held by the trust."}],"balance_after":243549,"source":{"system":"sec-edgar","filing":"0001579397-25-000007","document":"form4-12092025_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000157939725000007/form4-12092025_091203.xml","form_type":"4"}},{"id":984833,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2025-12-01T21:00:05.000Z","date":"2025-11-26","kind":"gift","planned":false,"acquired":false,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person transferred 225,000 shares to the Kovacs 2025 Family Trust as a bona fide gift for no consideration. The reporting person does not have voting, dispositive, or pecuniary interest over any of the securities held by the trust."}],"balance_after":318549,"source":{"system":"sec-edgar","filing":"0001579397-25-000005","document":"form4-12012025_091201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000157939725000005/form4-12012025_091201.xml","form_type":"4"}},{"id":1235212,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-03T16:16:48.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":320000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on February 28, 2026 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":320000,"derivative":{"exercise_price":4.37,"expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001415889-25-006151","document":"form4-03032025_090344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588925006151/form4-03032025_090344.xml","form_type":"4"}},{"id":1335109,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2024-12-11T19:53:28.000Z","date":"2024-12-11","kind":"sale","planned":false,"acquired":false,"shares":406,"price":9.39,"value":3812.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $9.39, and the range of prices was between $9.31 and $9.74. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":543549,"source":{"system":"sec-edgar","filing":"0001415889-24-029025","document":"form4-12122024_121223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588924029025/form4-12122024_121223.xml","form_type":"4"}},{"id":1335108,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2024-12-11T19:53:28.000Z","date":"2024-12-11","kind":"sale","planned":false,"acquired":false,"shares":17950,"price":8.66,"value":155447.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $8.66, and the range of prices was between $8.22 and $9.21. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":543955,"source":{"system":"sec-edgar","filing":"0001415889-24-029025","document":"form4-12122024_121223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588924029025/form4-12122024_121223.xml","form_type":"4"}},{"id":1335107,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2024-12-11T19:53:28.000Z","date":"2024-12-10","kind":"sale","planned":false,"acquired":false,"shares":16803,"price":9.37,"value":157444.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $9.37, and the range of prices was between $8.87 and $9.67. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":561905,"source":{"system":"sec-edgar","filing":"0001415889-24-029025","document":"form4-12122024_121223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588924029025/form4-12122024_121223.xml","form_type":"4"}},{"id":1335106,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2024-12-11T19:53:28.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":68250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 11, 2022, the Reporting Person was granted certain performance restricted stock units (\"PRSUs\") for 105,000 shares, which were subject to vesting upon certification by the Compensation Committee of the Company's achievement of two different performance milestones. 35% of the award previously vested on November 20, 2023. On December 9, 2024, the Compensation Committee certified that the remaining 65% of the award vested based on achievement of certain performance criteria."}],"balance_after":578708,"source":{"system":"sec-edgar","filing":"0001415889-24-029025","document":"form4-12122024_121223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588924029025/form4-12122024_121223.xml","form_type":"4"}},{"id":1361404,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Ch. Operating & Financial Off."}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-18T06:00:06.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":162000,"derivative":{"exercise_price":7.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-24-027022","document":"form4-11182024_061102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588924027022/form4-11182024_061102.xml","form_type":"4"}},{"id":1361403,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Ch. Operating & Financial Off."}}],"security":"Common Stock","published_at":"2024-11-18T06:00:06.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":7.02,"value":175500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 471 shares acquired under the issuer's Employee Stock Purchase Plan on June 28, 2024."}],"balance_after":510458,"source":{"system":"sec-edgar","filing":"0001415889-24-027022","document":"form4-11182024_061102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588924027022/form4-11182024_061102.xml","form_type":"4"}},{"id":1658187,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T17:30:23.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":304500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on February 1, 2025 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":304500,"derivative":{"exercise_price":15.25,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":304500},"source":{"system":"sec-edgar","filing":"0001415889-24-002608","document":"form4-02052024_050206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588924002608/form4-02052024_050206.xml","form_type":"4"}},{"id":1678954,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-16T07:30:07.000Z","date":"2024-01-12","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":187000,"derivative":{"exercise_price":7.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-001062","document":"form4-01162024_070101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588924001062/form4-01162024_070101.xml","form_type":"4"}},{"id":1678953,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2024-01-16T07:30:07.000Z","date":"2024-01-12","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":7.02,"value":351000.0,"ownership":{"direct":true},"balance_after":484987,"source":{"system":"sec-edgar","filing":"0001415889-24-001062","document":"form4-01162024_070101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588924001062/form4-01162024_070101.xml","form_type":"4"}},{"id":1713620,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-12T17:55:14.000Z","date":"2023-12-12","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":237000,"derivative":{"exercise_price":7.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-23-016322","document":"form4-12122023_051203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588923016322/form4-12122023_051203.xml","form_type":"4"}},{"id":1713619,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2023-12-12T17:55:14.000Z","date":"2023-12-12","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":7.02,"value":70200.0,"ownership":{"direct":true},"balance_after":434987,"source":{"system":"sec-edgar","filing":"0001415889-23-016322","document":"form4-12122023_051203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588923016322/form4-12122023_051203.xml","form_type":"4"}},{"id":1730789,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2023-11-22T19:00:13.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":9145,"price":13.89,"value":127024.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $13.89, and the range of prices was between $13.62 and $14.17. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":424987,"source":{"system":"sec-edgar","filing":"0001415889-23-015455","document":"form4-11222023_071101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588923015455/form4-11222023_071101.xml","form_type":"4"}},{"id":1730788,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2023-11-22T19:00:13.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":700,"price":15.27,"value":10689.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $15.27, and the range of prices was between $15.22 and $15.38. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":434132,"source":{"system":"sec-edgar","filing":"0001415889-23-015455","document":"form4-11222023_071101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588923015455/form4-11222023_071101.xml","form_type":"4"}},{"id":1730787,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2023-11-22T19:00:13.000Z","date":"2023-11-21","kind":"sale","planned":false,"acquired":false,"shares":8897,"price":14.83,"value":131942.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PRSUs. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $14.83, and the range of prices was between $14.18 and $15.17. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":434832,"source":{"system":"sec-edgar","filing":"0001415889-23-015455","document":"form4-11222023_071101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588923015455/form4-11222023_071101.xml","form_type":"4"}},{"id":1730786,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2023-11-22T19:00:13.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":36750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 11, 2022, the Reporting Person was granted certain performance restricted stock units (\"PRSUs\") for 105,000 shares, which are subject to vesting upon certification by the Compensation Committee of the Company's achieving two different performance milestones. The Compensation Committee certified on November 20, 2023 that 35% of the award vested based upon the certification by the Compensation Committee as to certain performance criteria."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,034 shares acquired under the issuer's Employee Stock Purchase Plan on May 15, 2023 and 1,748 shares acquired under the issuer's Employee Stock Purchase Plan on November 15, 2023."}],"balance_after":443729,"source":{"system":"sec-edgar","filing":"0001415889-23-015455","document":"form4-11222023_071101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588923015455/form4-11222023_071101.xml","form_type":"4"}},{"id":1922804,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2023-04-07T16:30:16.000Z","date":"2023-04-06","kind":"purchase","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $3.4173, and the range of prices were between $3.375 and $3.42. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":396197,"source":{"system":"sec-edgar","filing":"0001415889-23-006359","document":"form4-04072023_040409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588923006359/form4-04072023_040409.xml","form_type":"4"}},{"id":2035197,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Ch. Operating & Financial Off."}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T17:31:27.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":200000,"derivative":{"exercise_price":4.87,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-23-006286","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000120919123006286/doc4.xml","form_type":"4"}},{"id":2165067,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Common Stock","published_at":"2022-09-06T16:26:36.000Z","date":"2022-09-02","kind":"purchase","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction reported was $3.59, and the range of prices were between $3.53 and $3.60. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,517 shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":381197,"source":{"system":"sec-edgar","filing":"0001415889-22-009373","document":"form4-09062022_010928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588922009373/form4-09062022_010928.xml","form_type":"4"}},{"id":2412985,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CH. OPERATING & FINANCIAL OFF."}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T19:04:28.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":247000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":247000,"derivative":{"exercise_price":7.02,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":247000},"source":{"system":"sec-edgar","filing":"0001415889-22-001056","document":"form4-02032022_040213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000141588922001056/form4-02032022_040213.xml","form_type":"4"}},{"id":2972681,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Ch. Operating & Financial Off."}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T18:47:11.000Z","date":"2020-11-18","kind":"grant","acquired":true,"shares":107604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on November 18, 2021 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":107604,"derivative":{"exercise_price":19,"expiration_date":"2030-11-17","underlying":"Common Stock","underlying_shares":107604},"source":{"system":"sec-edgar","filing":"0001209191-20-059517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000120919120059517/doc4.xml","form_type":"4"}},{"id":2972680,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Ch. Operating & Financial Off."}}],"security":"Common Stock","published_at":"2020-11-19T18:47:11.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":358680,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":358680,"source":{"system":"sec-edgar","filing":"0001209191-20-059517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579397/000120919120059517/doc4.xml","form_type":"4"}},{"id":4325345,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2017-05-11T21:20:32.000Z","date":"2017-05-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on May 22, 2013, with 25% of the shares underlying the option vested on May 22, 2014, and an additional 2.083% of the original number of shares underlying the option vesting on a monthly basis thereafter, beginning on June 30, 2014."}],"balance_after":45625,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001070081-17-000086","document":"wf-form4_149453761648390.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000086/wf-form4_149453761648390.xml","form_type":"4"}},{"id":4325344,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-11T21:20:32.000Z","date":"2017-05-09","kind":"exercise","acquired":true,"shares":10000,"price":10.85,"value":108500.0,"ownership":{"direct":true},"balance_after":37850,"source":{"system":"sec-edgar","filing":"0001070081-17-000086","document":"wf-form4_149453761648390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000086/wf-form4_149453761648390.xml","form_type":"4"}},{"id":4499397,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2017-01-06T00:12:36.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018."}],"balance_after":52500,"derivative":{"exercise_price":11.23,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001070081-17-000022","document":"wf-form4_148366154289045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000022/wf-form4_148366154289045.xml","form_type":"4"}},{"id":4499396,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-01-06T00:12:36.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018."}],"balance_after":27850,"source":{"system":"sec-edgar","filing":"0001070081-17-000022","document":"wf-form4_148366154289045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000022/wf-form4_148366154289045.xml","form_type":"4"}},{"id":4595306,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-26T20:37:35.000Z","date":"2016-09-26","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on May 22, 2013, with 25% of the shares underlying the option vested on May 22, 2014, and an additional 2.083% of the original number of shares underlying the option vesting on a monthly basis thereafter, beginning on June 30, 2014."}],"balance_after":55625,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-16-030032","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911016030032/edgar.xml","form_type":"4"}},{"id":4595305,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":69321,"kind":"person","name":"Kovacs Shane William Charles","position":1,"cik":"0001579397","reported_name":"Kovacs Shane William Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-09-26T20:37:35.000Z","date":"2016-09-26","kind":"exercise","acquired":true,"shares":10000,"price":10.85,"value":108500.0,"ownership":{"direct":true},"balance_after":18850,"source":{"system":"sec-edgar","filing":"0001179110-16-030032","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911016030032/edgar.xml","form_type":"4"}}]}